## Abstract Given the strong etiologic link between highβrisk HPV infection and cervical cancer highβrisk HPV testing is now being considered as an alternative for cytologyβbased cervical cancer screening. Many test systems have been developed that can detect the broad spectrum of hrHPV types in on
The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population
β Scribed by M. INOUE; J. SAKAGUCHI; T. SASAGAWA; M. TANGO
- Book ID
- 109085688
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 108 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The APTIMA V R HPV Assay (AHPV) allows detection of 14 high-risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to HPV DNA tests only in triage settings. Herein, we compare AHPV with a DNA assay (Hybrid Capture V R 2; HC2) and liquid-based cyto
Objective: The aim of this study was to identify human papillomavirus (HPV) in cervical intraepithelial neoplasia (CIN) lesions and to evaluate the persistence of viral DNA after diathermic large loop excision (DLLE) treatment. Study Design: Biopsies from 36 patients with low-and high-grade CIN les
## Abstract The knowledge that cervical neoplasia are caused by human papillomavirus (HPV) infection has led to the evaluation of its role in screening. We evaluated the accuracy of HPV testing by Hybrid capture II (HC II) method in detecting cervical intraepithelial neoplasia grade 2 and 3 (CIN 2